Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Chang Ma

Email
Center AffiliationsMolecular Therapeutics

Publications (226) (print view)

no pagination
Berger MJ, Ettinger DS, Aston J, Barbour S, Bergsbaken J, Bierman PJ, Brandt D, Dolan DE, Ellis G, Kim EJ, Kirkegaard S, Kloth DD, Lagman R, Lim D, Loprinzi C, Ma CX, Maurer V, Michaud LB, Nabell LM, Noonan K, Roeland E, Rugo HS, Schwartzberg LS, Scullion B, Timoney J, Todaro B, Urba SG, Shead DA, Hughes M. NCCN Guidelines Insights: Antiemesis, Version 2.2017. J Natl Compr Canc Netw. 2017 Jul;15(7):883-93.
Huang JF, Zhang FZ, Zou QZ, Zhou LY, Yang B, Chu JJ, Yu JH, Zhang HW, Yuan XP, Tai GM, Liu FJ, Ma CC. Induction chemotherapy followed by concurrent chemoradiation and nimotuzumab for locoregionally advanced nasopharyngeal carcinoma: Preliminary results from a phase II clinical trial. Oncotarget. 2017 Jan;8(2):2457-65.
Huang JF, Zhang FZ, Zou QZ, Zhou LY, Yang B, Chu JJ, Yu JH, Zhang HW, Yuan XP, Tai GM, Liu FJ, Ma CC. Induction chemotherapy followed by concurrent chemoradiation and nimotuzumab for locoregionally advanced nasopharyngeal carcinoma: Preliminary results from a phase II clinical trial. Oncotarget. 2017 Jan 10;8(2):2457-65.   PMCID: PMC5356815
Huang JF, Zhang FZ, Zou QZ, Zhou LY, Yang B, Chu JJ, Yu JH, Zhang HW, Yuan XP, Tai GM, Liu FJ, Ma CC. Induction chemotherapy followed by concurrent chemoradiation and nimotuzumab for locoregionally advanced nasopharyngeal carcinoma: preliminary results from a phase II clinical trial. Oncotarget. 2017 Jan 10;8(2):2457-65.
Li PD, Hu JL, Ma C, Ma H, Yao J, Chen LL, Chen J, Cheng TT, Yang KY, Wu G, Zhang WJ, Cao RB. Upregulation of the long non-coding RNA PVT1 promotes esophageal squamous cell carcinoma progression by acting as a molecular sponge of miR-203 and LASP1. Oncotarget. 2017 May 23;8(21):34164-76.   PMCID: PMC5470958
Li PD, Liu Z, Cheng TT, Luo WG, Yao J, Chen J, Zou ZW, Chen LL, Ma C, Dai XF. Redox-dependent modulation of metformin contributes to enhanced sensitivity of esophageal squamous cell carcinoma to cisplatin. Oncotarget. 2017 Sep 22;8(37):62057-68.   PMCID: PMC5617486
Liu T, Kan XF, Ma C, Chen LL, Cheng TT, Zou ZW, Li Y, Cao FJ, Zhang WJ, Yao J, Li PD. GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2017 Jun;39(6):1010428317700410.
Meyer JE, Finnberg NK, Chen L, Cvetkovic D, Wang B, Zhou L, Dong Y, Hallman MA, Ma CC, El-Deiry WS. Tissue TGF-beta expression following conventional radiotherapy and pulsed low-dose-rate radiation. Cell cycle (Georgetown, Tex). 2017 Jun 18;16(12):1171-4.   PMCID: PMC5499842
Shaikh T, Li T, Handorf EA, Johnson ME, Wang LS, Hallman MA, Greenberg RE, Price RA, Uzzo RG, Ma C, Chen D, Geynisman DM, Pollack A, Horwitz EM. Long-Term Patient-Reported Outcomes From a Phase 3 Randomized Prospective Trial of Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer. Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):722-31.   PMCID: PMC5331910
Afifi M, Deiab N, El-Farrash A, Abd El-Hafez A, Eldib A, Veltchev I, Ma C. SU-F-T-281: Monte Carlo Investigation of Sources of Dosimetric Discrepancies with 2D Arrays. Med Phys. 2016 Jun;43(6):3527.
Afifi M, Deiab N, El-Farrash A, Abd El-Hafez A, Eldib A, Veltchev I, Ma C. SU-F-T-281: Monte Carlo Investigation of Sources of Dosimetric Discrepancies with 2D Arrays. Med Phys. 2016 Jun;43(6):3527.
Afifi M, Deiab N, El-Farrash A, Abd El-Hafez A, Eldib A, Veltchev I, Ma C. SU-F-T-281: Monte Carlo Investigation of Sources of Dosimetric Discrepancies with 2D Arrays. Med Phys. 2016 Jun;43(6):3527.
Al Ashkar E, Eldib A, Eraba K, Imam M, Ma C. SU-F-T-79: Monte Carlo Investigation of Optimizing Parameters for Modulated Electron Arc Therapy. Med Phys. 2016 Jun;43(6):3479.
Al Ashkar E, Eldib A, Eraba K, Imam M, Ma C. SU-F-T-79: Monte Carlo Investigation of Optimizing Parameters for Modulated Electron Arc Therapy. Med Phys. 2016 Jun;43(6):3479.
Chen L, Cvetkovic D, Chen X, Wang B, Gupta R, Ma C. SU-F-J-225: Histology Study of MR Guided Pulsed Focused Ultrasound On Treatment of Prostate Cancer in Vivo. Med Phys. 2016 Jun;43(6):3460-1.
Chen L, Cvetkovic D, Chen X, Wang B, Gupta R, Ma C. WE-AB-BRA-02: Study of the Therapeutic Effects of Pulsed Focused Ultrasound Combined with Encapsulated Chemotherapeutic Agents for Prostate Cancer in Vivo. Med Phys. 2016 Jun;43(6):3791.
Chen L, Cvetkovic D, Chen X, Wang B, Gupta R, Ma C. WE-AB-BRA-02: Study of the Therapeutic Effects of Pulsed Focused Ultrasound Combined with Encapsulated Chemotherapeutic Agents for Prostate Cancer in Vivo. Med Phys. 2016 Jun;43(6):3791.
Chen L, Cvetkovic D, Chen X, Wang B, Gupta R, Ma C. SU-F-J-225: Histology Study of MR Guided Pulsed Focused Ultrasound On Treatment of Prostate Cancer in Vivo. Med Phys. 2016 Jun;43(6):3460-1.
Chen L, Cvetkovic D, Wang B, Gupta R, Ma CM. Management of Prostate Cancer Using Magnetic Resonance Guided Pulsed Focused Ultrasound-Mediated Targeted Chemotherapeutic Agent Delivery. Int J Radiat Oncol Biol Phys. 2016 Oct;96(2S):E260.
Chibani O, Fan J, Tahanout F, Eldib A, Ma C. SU-F-T-375: Optimization of a New Co-60 Machine for Intensity Modulated Radiation Therapy: A Monte Carlo Characterization Study. Med Phys. 2016 Jun;43(6):3549.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

Chang Ma Sparkline Graph

Graph Interactions

Co-Authors:

Similar Investigators:


Keywords (MeSH):


Last updated on Thursday, November 02, 2017